Page last updated: 2024-08-24

oseltamivir and Pneumococcal Infections

oseltamivir has been researched along with Pneumococcal Infections in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Amaro, R; Bassetti, M; Cilloniz, C; Giacobbe, DR; Graziano, E; Russo, A; Soriano, A; Torres, A; Vena, A1
Homma, T; Kitano, M; Kobayashi, M; Naito, A; Onishi, M; Sato, A; Taniguchi, K; Yoshinaga, T1
Boianelli, A; Bruder, D; Hernandez-Vargas, EA; Sharma-Chawla, N1
Owen Hendley, J; Pappas, DE1
Fukunaga, Y; Hajikano, M; Kawabata, K; Madenokouji, N; Matsuoka, K; Ninomiya, K1

Reviews

1 review(s) available for oseltamivir and Pneumococcal Infections

ArticleYear
Otitis media. A scholarly review of the evidence.
    Minerva pediatrica, 2003, Volume: 55, Issue:5

    Topics: Acetamides; Acute Disease; Age Factors; Amoxicillin; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Humans; Infant; Influenza Vaccines; Influenza, Human; Meta-Analysis as Topic; Oseltamivir; Otitis Media; Otitis Media with Effusion; Placebos; Pneumococcal Infections; Pneumococcal Vaccines; Randomized Controlled Trials as Topic; Recurrence; Streptococcus pneumoniae; Time Factors

2003

Other Studies

4 other study(ies) available for oseltamivir and Pneumococcal Infections

ArticleYear
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Italy; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oseltamivir; Pneumococcal Infections; Pneumonia; Retrospective Studies; Spain; Staphylococcal Infections; Streptococcus pneumoniae

2020
Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Antiviral research, 2015, Volume: 117

    Topics: Acids, Carbocyclic; Administration, Intravenous; Animals; Antiviral Agents; Bacterial Load; Coinfection; Cyclopentanes; Cytokines; Disease Models, Animal; Dogs; Guanidines; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Oseltamivir; Pneumococcal Infections; Streptococcus pneumoniae; Viral Load; Virus Replication

2015
Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.
    Frontiers in cellular and infection microbiology, 2016, Volume: 6

    Topics: Anti-Bacterial Agents; Antiviral Agents; Coinfection; Computer Simulation; Humans; Influenza A virus; Influenza, Human; Models, Theoretical; Neuraminidase; Oseltamivir; Pneumococcal Infections; Streptococcus pneumoniae

2016
Frequency and effects of bacterial infection in children with influenza under oseltamivir treatment.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2006, Volume: 73, Issue:3

    Topics: Acetamides; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Female; Fever; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Japan; Male; Oseltamivir; Pneumococcal Infections; Superinfection; Time Factors

2006